Navigation Links
Certain Skin Cancers More Common in HIV-Positive People
Date:2/1/2013

FRIDAY, Feb. 1 (HealthDay News) -- Non-melanoma skin cancers are more common among people who are HIV-positive, according to new research.

The study found that basal cell and squamous cell carcinomas, two of the most common forms of cancer in the United States, occur more than twice as often among those with HIV (the virus that causes AIDS).

The greater risk for cancer among people with HIV is likely due to immune system deficiency, the researchers said, and those with the virus should take extra precautions to protect and monitor their skin.

"The clinical implications for these findings include increased vigilance in skin-cancer screening for HIV-positive individuals, especially for squamous cell carcinomas and particularly for those who are not on antiretroviral therapy or who were diagnosed late and have more advanced HIV/AIDS," senior study author Dr. Maryam Asgari, a dermatologist and investigator at Kaiser Permanente's division of research, said in a Kaiser news release.

"HIV-positive individuals should also be advised to reduce behaviors that may further increase non-melanoma skin cancer incidence, such as excessive sun exposure," Asgari added.

The study, using data from 1996 to 2008, involved more than 6,500 HIV-positive patients and nearly 37,000 other patients who tested HIV-negative.

HIV-positive patients were more than twice as likely to develop basal cell carcinomas, the study revealed. They also were nearly three times more likely to be diagnosed with squamous cell carcinomas.

Patients with squamous cell carcinomas often had lower CD4 counts, which is a measure of immunodeficiency. The researches noted that previous treatment with antiviral therapy was not linked to either form of skin cancer.

Lead study author Michael Silverberg, also of Kaiser's division of research, said, "These findings represent unique data on non-melanoma skin cancers in HIV patients. Most cancer registries, on which previous studies relied, do not record these types of cancers."

"Given the increasing longevity for HIV-positive individuals, the burden of many age-related, non-AIDS-defining cancers, including [non-melanoma skin cancers], will only continue to increase," Silverberg said. "Based on our studies, non-melanoma skin cancers are by far the most common cancer this population experiences."

The findings have implications for changes in treatment, Asgari said.

"Given the observed association of immunodeficiency and squamous cell carcinomas, earlier initiation of antiretroviral therapy to maintain higher CD4 counts may also help reduce the burden of this cancer," she said.

More than 3.5 million new cases of non-melanoma skin cancers are diagnosed in the United States each year. Although most of these cases can be easily cured, many become locally invasive and destructive, according to the release.

The study, funded by research grants from Pfizer, Kaiser Permanente Northern California Community Benefit and the U.S. National Institutes of Health, was recently published online in the Journal of the National Cancer Institute.

More information

The American Cancer Society has more about skin cancer.

-- Mary Elizabeth Dallas

SOURCE: Kaiser Permanente, news release, Jan. 29, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
2. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
3. Codeine After Surgery Could Endanger Certain Kids: Study
4. Decision guide reduced uncertainty over breast cancer prevention, study finds
5. Certain Genetic Regions May Be Tied to Osteoporosis
6. Hot Flashes More Likely for Certain Smokers, Study Says
7. Early Study Hints at Link Between Certain Sunscreens, Endometriosis
8. Cabazitaxel can offer an advantage in certain patients
9. Antioxidant shows promise as treatment for certain features of autism, Stanford study finds
10. Gout Flare-ups Rise Sharply With Certain Foods: Study
11. Mouse Study Suggests Certain Fats Could Trigger Crohns, Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain Skin Cancers More Common in HIV-Positive People
(Date:5/30/2016)... , ... May 30, 2016 , ... ... businesses, announced today the publication of an original infographic, " Health Benefits Reimbursement ... insurance professionals understand how Zane Benefits complies with various federal regulations and reforms. ...
(Date:5/29/2016)... (PRWEB) , ... May 29, 2016 , ... Whole Health ... jaw clipper that has been available via Amazon.com. This new style of nail ... nails. , The jaw opening is approximately 4mm and the actual handle is 2.5mm ...
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... day issues, struggles and obstacles veterans’ need to overcome in order to face their ... or retired military veteran(s) with a donated SuperCloset product based on the needs and ...
(Date:5/28/2016)... CT (PRWEB) , ... May 28, 2016 , ... After a year and a half ... it was an extraordinary event. The Multiple Pathways of Recovery Conference was held May ... across the country and the United Kingdom came together to explore the many pathways individuals ...
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Hutchison China MediTech (Chi-Med) ... the highly lucrative global oncology and immunology markets. ... first-in-class or best-in-class tyrosine kinase inhibitor (TKI) drugs, ... partners. HCM,s profitable Chinese healthcare business continues to ... progress of the mid-to-late-stage pipeline during 2016-17 (including ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
Breaking Medicine Technology: